ICYMI 🔎: An #FDA advisory panel has backed the Galleri MCED test for adults 50+, citing strong specificity, mixed sensitivity, and follow-up impacts as FDA weighs approval.
Read more about the decision: targetedonc.com/view/fda-pan...
#MCEDTest #CancerScreening #CancerDiagnosis
Read more about the decision: targetedonc.com/view/fda-pan...
#MCEDTest #CancerScreening #CancerDiagnosis
FDA Panel Votes in Favor of Galleri Multi-Cancer Early Detection Test | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Advisory panel backs Galleri blood test for adults 50+, citing strong specificity, mixed sensitivity, and follow-up impacts as FDA weighs approval.
targetedonc.com
September 29, 2026 at 8:03 PM
ICYMI 🔎: An #FDA advisory panel has backed the Galleri MCED test for adults 50+, citing strong specificity, mixed sensitivity, and follow-up impacts as FDA weighs approval.
Read more about the decision: targetedonc.com/view/fda-pan...
#MCEDTest #CancerScreening #CancerDiagnosis
Read more about the decision: targetedonc.com/view/fda-pan...
#MCEDTest #CancerScreening #CancerDiagnosis
#ovariancancer #oncology #WorldOvarianCancerDay #WOCD #CancerResearchUK #WorldOvarianCancerCoalition #EveryWomanStudy #MCEDtest #CancerSignalDetectedtestresult #OvarianCancerAction #TheEveAppeal #OvarianVax #CancerResearchUK #OseImmunotherapeutics #CellxLife #biotech
zurl.co/vdHgo
zurl.co/vdHgo
Solving the ovarian cancer diagnostic and treatment pathway problem
pharmaphorum.com
August 14, 2026 at 10:35 AM